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Summary
Objective: Congenital dislocation of the hip (CDH), which is one of the most common congenital skeletal disorders, corresponds to an abnor-
mal seating of the femoral head in the acetabulum. It is commonly admitted that CDH presents a genetic component. However, little is known
about the genetic factors involved. This study aimed to determine the role of two potential candidate genes on chromosome 17 in CDH:
HOXB9 (involved in limb embryonic development) and COL1A1 (involved in joint laxity).
Method: We set up a case-control association study (239 cases and 239 controls) in western Brittany (France) where CDH is particularly fre-
quent. The set of informative single nucleotide polymorphisms (SNPs) in each gene was selected using Tagger and genotyped using the
SNaPshot method (n¼ 2 and n¼ 10, respectively). The association was tested both through single-locus and haplotype-based analyses,
using SAS and Haploview softwares. In addition, we carried out the transmission disequilibrium test (TDT) with the same polymorphisms
from a sample of 81 trios (i.e., 81 patients included in the case-control study and their both parents).
Results: The case-control study revealed no signiﬁcant association between CDH and the tagSNPs selected in both HOXB9 and COL1A1.
Moreover, the TDT did not reveal distortion in allelic and haplotype transmission of the studied markers.
Conclusion: Our study did not support an association between HOXB9 and COL1A1 and CDH in our population. These negative ﬁndings were
obtained by population- and family-based designs. Analysis of the genetic component of CDH should focus on other candidate genes.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Congenital dislocation of the hip (CDH e OMIM #142700) is
one of the most common congenital skeletal disorders. It re-
sults from an abnormality of the seating of the femoral head
in the acetabulum1e3. The condition, which affects mainly
females (sex-ratio: 1:8), may induce severe functional
handicap if not treated early, and increases risk to develop
hip osteoarthritis4,5.
CDH is particularly frequent in Caucasian populations,
with an incidence about 1e10 per 1000 live births. Clusters
of CDH have been observed in some ethnic groups such as
the Navajo Indians (67/1000)6 and the Lapps (50/1000)7,*Address correspondence and reprint requests to: Virginie
Scotet, Inserm U613 « Ge´ne´tique mole´culaire et ge´ne´tique
e´pide´miologique », 46, rue Fe´lix Le Dantec, BP 62026, 29220
Brest cedex 2, France. Tel: 33-2-98-44-50-64; Fax: 33-2-98-43-
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1099but this condition is also very common in our area (Finiste`re,
western Brittany, France). An epidemiological study per-
formed in the 1960s showed that the incidence among girls
reached 38/1000 in a speciﬁc area called ‘‘Pays
Bigouden’’8,9.
Besides a mechanical component linked to the preg-
nancy and delivery conditions, it is commonly admitted
that CDH presents a genetic component. The main factors
that argue in favor of a genetic determination for the disease
are the ethnic predisposition and the familial aggregation
observed. Higher recurrence risks of CDH have been re-
ported in ﬁrst-degree relatives of patients10,11, as well as
higher concordance in monozygotic than in dizygotic twins
(40% vs 3%)12. The hereditary transmission has also
been highlighted in a large segregation analysis performed
on 171 pedigrees13. In addition, the availability of animal
models supports the genetic hypothesis. Hip dysplasia oc-
curs with a high frequency in some breed canine varieties,
such as German Shepherd dogs and Labrador
1100 K. Rouault et al.: Role of COL1A1 and HOXB9 in CDHRetrievers14, and several recent linkage analyses have
pointed out various regions of interest in the canine
genome15e17.
CDH can be considered as a multifactorial disease, how-
ever little is known about the genetic factors involved. It has
been suggested that the genetic predisposition to CDH could
involve two genetic systems: the ﬁrst one linked to acetabular
dysplasia (corresponding to a shallow acetabulum at birth)
and the second one linked to capsular joint laxity (correspond-
ing to a weak mechanical resistance of the capsule that could
result from a defect of the connective tissue)18e20.
The genetic factors involved in CDH may therefore affect
acetabular morphology or capsular laxity. Two genes lo-
cated on chromosome 17 at position 17q21.3 appear as in-
teresting candidate genes. The ﬁrst one e HOXB9 e is
included in a cluster of Homeobox genes and the encoded
protein functions as a sequence-speciﬁc transcription fac-
tor, which is involved in cell proliferation and differentiation.
The HOX genes are essential for limb development, where
they participate in both growth and organization of the struc-
tures21,22. The second gene e COL1A1 e belongs to the
superfamily of genes encoding collagen; it encodes the
a1 chain of collagen type 1. Such genes are of particular in-
terest because of their involvement in resistance and elas-
ticity of the tissues. They have been associated with a large
spectrum of diseases such as EhlerseDanlos syndrome,
osteogenesis imperfecta, chondrodysplasia and low bone
mineral density23. Moreover, biochemical studies have
shown that CDH is associated with alterations in the metab-
olism of collagen, which could explain the joint laxity ob-
served24. The involvement of these two genes in CDH
has been suggested by a Chinese study which, later on, re-
futed the implication of COL1A125,26.
In view of these ambiguous ﬁndings, we proposed to
study the association between HOXB9 and COL1A1 genes
and CDH in our area (western Brittany, France) where this
condition is particularly frequent. We used both case-control
and family-based approaches to examine the role of these
genes.
MethodSTUDY DESIGNIn order to determine whether HOXB9 and COL1A1 may play a role in
CDH, we set up a genetic-based association study in the area of Finiste`re
(Brittany, western France) where that condition is particularly frequent8,9.
Four centres involved in the screening and treatment of CDH in this area par-
ticipated in the study (Hospital of Brest, Pont L’Abbe´, Quimper and Roscoff)
(Fig. 1).Fig. 1. Centres involved in the study.POPULATION UNDER STUDYWe carried out a case-control association study which included 239 unre-
lated patients and 239 healthy subjects mostly from western Brittany. Pa-
tients were mainly recruited in the four study centres by expert surgeons,
who also validated the inclusion of the patients followed in other medical cen-
tres. The recruiting was done both prospectively (for the younger patients)
and retrospectively (for the older ones). The diagnosis of CDH was made
on the basis of clinical criteria and ultrasound and/or radiographic examina-
tion depending on the age and time of treatment. Only severe cases were
enrolled in the study, what corresponded to the grades III and IV of the sono-
graphic classiﬁcation proposed by Graf and Wilson for newborns27. For
adults, the classiﬁcation relies on the VCE (vertical center edge or Wiberg
angle e <20) and HTE (horizontal toit externe or To¨nnis angle e >12) an-
gle measures, which respectively assess the coverage and the inclination of
the acetabulum. Patients with elastic tissue diseases (EhlerseDanlos,
Larsen and Marfan syndromes, osteogenesis imperfecta) or karyotype ab-
normalities were excluded from the study. All the selection criteria had
been uniformly applied by the different study centres.
Healthy subjects were blood donors from the same area or patients con-
sulting in one of the four study centres. They did not have any family history
of CDH or hip disorders. The control group was matched for gender, age and
ethnic origin. Although the population of western Brittany is relatively ethni-
cally homogeneous (mostly of Celtic origin), we constructed a match for eth-
nic origin in order to minimize the risk of population substructure.
We completed the study of the two genes by using a family-based ap-
proach which relied on the transmission disequilibrium test (TDT). Analyses
were carried out from a sample of 81 complete trios composed of patients
from the case-control study and their both parents (i.e., patients for whom
we were able to obtain a blood sample for both parents).
Participation in the research protocol included the answer to a question-
naire (which provides information notably on family history and on mechan-
ical factors) and the collection of a blood sample by venipuncture. The blood
samples were prepared in accordance with usual procedures. DNA was ex-
tracted by a salting-out method and stored at 20C.
This research protocol was approved by our local Ethics Committee. Writ-
ten informed consent was obtained for all subjects prior to their inclusion in
the study.SELECTION AND GENOTYPING OF MARKERSThe two candidate genes we analyzed are located on chromosome 17
and separated by 1.4 million base pairs (bp). The ﬁrst one, HOXB9, is lo-
cated at position 17q21.3. It contains two exons and covers a region of
5317 bp. The second one, COL1A1, is located at position 17q21.33. It is
a long gene which contains 51 exons and covers a region of 17,543 bp.
The role of these two candidate genes in CDH was studied by choosing
several single nucleotide polymorphisms (SNPs) in each gene. The set of in-
formative SNPs (called tagSNPs) was selected using the Tagger software
(http://www.broad.mit.edu/mpg/tagger/)28, which integrates the data of the
HapMap Project29e32. This selection was made in reference to the Cauca-
sian population (CEU population), ensuring that all the SNPs with a minor al-
lele frequency 5% have a pair-wise r2 80% with at least one of the
tagSNPs. Respectively two and eight SNPs were selected in the HOXB9
and COL1A1 genes (HOXB9: rs8844 and rs2303486; COL1A1:
rs1061947, rs2586488, rs2075559, rs2857396, rs2696247, rs2141279,
rs17639446 and rs2075555). Two additional SNPs were selected in the 30
and the 50 regions of the longest gene (COL1A1: rs909102 and
rs1107946). Genotyping of SNPs was performed by an allelic discrimination
technique (SNaPshot) on an ABI Prism 3130 instrument (Applied Biosys-
tems, Inc.). We also genotyped, in our sample of trios, the microsatellite
marker studied by the Chinese team (D17S1820)25. Success rate of geno-
typing was 100%. In order to validate the accuracy of genotyping results,
we decided to retest, with an alternative technique (direct sequencing),
10% of the samples (for the SNPs showing the more divergent allelic fre-
quencies from those observed in HapMap).STATISTICAL ANALYSISFirst, deviation of genotype frequencies from HardyeWeinberg equilib-
rium (HWE) was tested for each SNP using the Finetti software
(http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). As illustrated in
Table I, all markers were in HWE and could therefore be considered for
further analyses. Then, we checked if the allelic frequencies observed in our
study were correlated with those observed in the HapMap database for the
CEUpopulation.Weobtainedanoverall correlation coefﬁcient of 80.1% (Table
I). PGA software was also used to perform power calculations33.
Case-control association study
First, we tested the association between each marker and CDH using the
SAS software (version 9.1 e SAS Institute, Cary, NC, USA). Logistic
Table I
Test of deviation from HWE for each SNP and correlation between
allelic frequencies observed in our sample and those in the Hap-
Map database





HOXB9 rs8844 A/G 0.407 A 0.092 0.044
rs2303486 A/T 0.811 A 0.397 0.322
COL1A1 rs909102 C/T 0.825 T 0.147 0.165
rs1061947 C/T 0.984 T 0.158 0.159
rs2586488 A/G 0.908 A 0.353 0.262
rs2075559 C/G 0.671 C 0.540 0.431
rs2857396 C/T 0.071 C 0.167 0.172
rs2696247 A/G 0.054 G 0.183 0.111
rs2141279 C/T 0.258 T 0.062 0.178
rs17639446 A/C 0.955 C 0.065 0.157
rs2075555 A/C 0.357 A 0.183 0.121
rs1107946 A/C 0.398 A 0.133 0.138
Fig. 2. Radiographic image of dislocation of the right hip.
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through calculation of odds-ratio (OR) with their 95% conﬁdence interval
(95% CI). The alternative patterns of inheritance (dominant, recessive and
multiplicative) were tested for each SNP by using a speciﬁc coding of the
‘‘genotype’’ variable. To account for multiple testing, the Bonferroni correc-
tion was applied. This consists in dividing the usual signiﬁcance level of
5% (i.e., the type I error rate called a) by the number of tests (i.e., mar-
kers genetic models) carried out in order to assure an overall signiﬁcance
level of not more than 5%. The analyses were conducted by considering all
patients, and then by excluding patients with the main risk factors known in
CDH beyond gender (breech presentation and family history of CDH).
After this single-locus association analysis, we carried out a haplotype-
based association study using Haploview (v4.0, http://www.broad.mit.edu/
mpg/haploview/)34 and Thesias (http://genecanvas.ecgene.net/uploads/The-
sias_Java_interface/)35. Haploview was used to visualize the structure of
pair-wise linkage disequilibrium (LD) between the markers (in terms of Lew-
ontin’s D0 and r2), and to deﬁne haplotype blocks within each gene. Haplo-
type frequencies were estimated from genotyping data using the stochastic
EM algorithm, and compared using the c2 test. In addition, Thesias enabled
us to test the association between the haplotypes and CDH by performing
a test of likelihood ratio (LRT) and by calculating OR with their 95% CIs.
TDT
We completed the analysis of the two candidate genes by performing the
TDT with the SNPs selected for the case-control study. As mentioned above,
we also performed this test with the microsatellite marker D17S1820 located
between the two genes. The TDT, which is insensitive to population subtruc-
ture36, is based on trios composed of affected individuals and both parents. It
determines whether a marker allele (or an haplotype) is preferentially trans-
mitted by heterozygous parents to their affected offspring37. The TDT was
carried out using the Etdt software38 whereas the haplotype-TDT analysis
was performed using Haploview34.ResultsDESCRIPTION OF THE SAMPLE OF CDH PATIENTSThe present study included 239 CDH patients, 91.2% of
whom were women (n¼ 218), leading to a sex-ratio of
1:10. A radiographic image of a case is shown in Fig. 2.
Overall, the condition was more often bilateral (60.8% vs
39.2%, P¼ 0.016), but when it was unilateral, it affected
as often the left as the right hip (50.5% vs 49.5%,
P¼ 0.854). Close to 80% of the patients had a positive fam-
ily history of CDH (n¼ 188).
As our questionnaire gives information on the main me-
chanical factors known to be involved in CDH, we described
the frequency of these factors in our series. Breech presen-
tation was observed in 12.5% of the CDH cases and highbirthweight (4 kg) in 15.1% of them. CDH affected the ﬁrst
sibling in 42.7% of cases and three patients were part of
multiple pregnancies. The proportion of postmature babies
(42 weeks of gestation) was 5.9%. A postural anomaly
was observed in 11.4% of the CDH patients. Among these
mechanical factors, only breech presentation was signiﬁ-
cantly more frequent in cases than in controls (12.5% vs
1.4%, OR¼ 10.1 [3.0e34.5], P< 0.0001). Joint hyperlaxity
was present in 11.0% of them and was also signiﬁcantly
more frequent in cases than in controls (11.0% vs 1.8%,
OR¼ 6.7 [2.3e19.7], P< 0.0001).RESULTS OF THE CASE-CONTROL STUDYThe case-control study was based on 239 patients and
239 controls. Two SNPs were genotyped in the HOXB9
gene, and 10 in the COL1A1 gene. Genotyping was suc-
cessful for all the markers in the whole sample. The accu-
racy of genotyping was validated in the way that the
sequencing results of the retested markers did not differ
from those obtained initially.
Single-locus association study
No signiﬁcant association was observed between the two
polymorphisms selected in HOXB9 and CDH. In contrast,
a weak association tended to be observed for two of the
SNPs selected in COL1A1, this before applying the Bonfer-
roni correction. The concerned markers were rs2857396
(CC vs CTþ TT: OR¼ 0.26 [0.07e0.96], P¼ 0.043) and
rs1107946 (AAþ AC vs CC: OR¼ 0.63 [0.41e0.98],
P¼ 0.038), for which study power was respectively as-
sessed to 90% and 67%. However, the signiﬁcance of these
results did not survive correction for multiple testing. More-
over, the complementary analyses performed in the sub-
group of patients without breech presentation and in the
subgroup without family history revealed no signiﬁcant as-
sociation (data available upon request).
Haplotype-based association study
LD and haplotype blocks observed for the two genes re-
vealed a single haplotype block in HOXB9 and three blocks
in COL1A1 (Fig. 3). Results of the haplotype analysis for
each gene are presented in Tables IIa and b. For HOXB9,
haplotype frequencies did not differ between cases and con-
trols. In contrast, for COL1A1, a weak association tended to
Fig. 3. COL1A1 gene: representation of LD (D0) between SNPs and of haplotype blocks.
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P¼ 0.0280) which included the markers rs2075555 and
rs1107946, the latter being associated with CDH in the sin-
gle-locus analysis. More precisely, frequency of the CC hap-
lotype was estimated at 89.7% in cases and 85.3% in
controls (P¼ 0.0396), whereas frequency of the CA haplo-
type was estimated at 0.6% in cases and 2.5% in controls
(P¼ 0.0193). Thus, by considering the most common haplo-
type (CC) as reference, the OR associated with the CA hap-
lotype was 0.23 (95% CI¼ [0.06e0.84], P¼ 0.026). Again,
the signiﬁcance of all these ﬁndings disappeared after cor-
rection for multiple testing.RESULTS OF THE TDTTable IIb






Block 1 CCGG 0.570 0.550 0.391 0.5316
CCGC 0.186 0.170 0.385 0.5349
TTAC 0.133 0.145 0.319 0.5724Analysis of the family data set revealed similar negative
ﬁndings. Table III shows, for each of the SNPs selected in
the HOXB9 and COL1A1 genes, the ratio of transmissions
to nontransmissions of the possibly overtransmitted allele
from heterozygous parents to their affected offspring. This
analysis did not reveal preferential transmission of any
alleles of the selected markers. The haplotype-based anal-
ysis found similar results. In the same way, no transmissionTable IIa






Block 1 GT 0.653 0.678 0.676 0.4108
GA 0.291 0.278 0.185 0.6671
AA 0.056 0.044 0.790 0.3742disequilibrium was observed for any of the 16 alleles of the
microsatellite marker D17S1820.
Discussion
The present study examines the involvement of two
genes on chromosome 17 (HOXB9 and COL1A1) in CDH
in a Caucasian population where the incidence of that con-
dition is high. These genes may play a role in acetabular
dysplasia or joint laxity, and are therefore interesting candi-
date genes.
Our ﬁndings do not support the role of these two genes in
CDH in our population. They are consistent with the results
observed in a Chinese population for the COL1A1 gene26.CCAC 0.092 0.111 0.894 0.3444
TTGG 0.007 0.014 0.884 0.3470
Block 2 TACA 0.445 0.389 3.035 0.0815
TATA 0.177 0.171 0.043 0.8351
CACA 0.149 0.165 0.451 0.5018
TACC 0.142 0.157 0.403 0.5256
TGCA 0.086 0.111 1.699 0.1924
Block 3 CC 0.897 0.853 4.235 0.0396
AA 0.094 0.113 0.911 0.3398
CA 0.006 0.025 5.471 0.0193
Table III
Results of the TDT for the SNPs selected in the HOXB9 and
COL1A1 genes
Gene SNP Allele overtransmitted T/UT* c2 P
HOXB9 rs8844 A 10/6 1.000 0.317
rs2303486 A 37/33 0.229 0.633
COL1A1 rs909102 e 13/13 0.000 1.000
rs1061947 C 13/12 0.040 0.842
rs2586488 A 27/24 0.176 0.674
rs2075559 G 46/31 2.922 0.087
rs2857396 T 17/16 0.030 0.862
rs2696247 G 16/10 1.385 0.239
rs2141279 T 22/17 0.641 0.423
rs17639446 C 22/14 1.778 0.183
rs2075555 C 15/9 1.500 0.221
rs1107946 C 16/9 1.960 0.162
*T/UT ¼ Ratio of transmissions (T) to untransmissions (UT) of
the overtransmitted allele.
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proaches (case-control and family-based studies) that rely
both on single-locus and haplotype-based analyses. More-
over, our study used selection methods of informative
markers based on LD information, contrary to previous
studies which usually consisted in genotyping only one or
two genetic markers per gene. Our sample is also one of
the largest used to date in genetic studies carried out on
CDH (even if it remains of modest size for such kind of stud-
ies). It should nevertheless be noted that family history of
CDH appears particularly frequent in our study. This could
be the result of several phenomena (high incidence of
CDH in our region, lack of accuracy of the variable based
on patients’ responses) and may have induced a selection
bias. Nevertheless, the results remain unchanged in the
subgroup of patients without family history.
It is commonly admitted that CDH involves genetic and
mechanical factors. The mechanical component is linked
to the conditions of pregnancy and delivery. It mainly corre-
sponds to factors that reduce the mobility of the fetus in the
womb and induce excessive pressure on the ﬂexed thigh-
bone. Among them, we note breech presentation, oligoam-
nios, primiparity, high birthweight, postmaturity and
presence of postural anomalies39.
Besides this mechanical component, the observation of
clusters of CDH and the familial nature of the condition
suggest the existence of a genetic component for CDH. Fa-
milial studies have reported higher risks of recurrence for
ﬁrst-degree relatives and showed that those risks increased
if several children or two generations were affected10. More-
over, twin studies have shown a higher concordance of
CDH in monozygotic twins (40%) compared with dizygotic
ones (3%)12.
Several authors suggested, in the 1960s, that two genetic
models could be responsible for the etiology of CDH: one
linked to acetabular dysplasia and one linked to joint lax-
ity18,19. Such laxity might result from an anomaly of the con-
nective tissue. Czeizel et al. showed that CDH patients had
a more extensible metacarpophalangeal joint of the index
than nondislocated subjects, and that this persistent laxity
was often found among ﬁrst-degree relatives (in 25% of par-
ents of cases, in 36% of siblings of cases)20. The two
models proposed seem to differ both in their genetic mech-
anism and in the age at which they anticipate diagnosis. It
was proposed that the genetic mechanism responsible for
anatomic conﬁguration of the hip should be of polygenic na-
ture whereas that responsible for joint laxity should be ofmonogenic nature19,20. Moreover, cases linked to acetabu-
lar dysplasia are usually diagnosed later than cases linked
to joint laxity, which may be detected at birth by the Ortola-
nieBarlow maneuvres40.
Few studies have tried to dissect the genetic basis of
CDH with the genetic tools currently available. To date,
only four genetic-based association studies and one linkage
analysis have been carried out25,26,41e43 and most of them
have obtained negative results.
The ﬁrst association study performed on CDH was con-
ducted in 2003 by a Chinese team and was published in
a Chinese journal25. It was a family-based study which ex-
amined the role of HOXB9 and COL1A1 in CDH using the
TDT approach. The authors genotyped a single microsatel-
lite marker (D17S1820) located between these two genes in
101 trios. They observed a transmission disequilibrium for
one of the twelve alleles identiﬁed in their sample
(P¼ 0.014), leading them to suggest that these genes could
confer susceptibility to CDH. Nevertheless, it should be
noted that these genes are distant from each other; the re-
gion separating them covers 1.4 million bp and contains
more than 20 other genes. We performed the same test in
our sample of trios, and did not observe any transmission
disequilibrium for any of the alleles of this marker. However,
our sample size (81 trios) remains small.
Thereafter, this team examined the role of COL1A1 more
thoroughly by selecting two polymorphisms within this large
gene26. The authors did not observe preferential transmis-
sion in that instance, and concluded that COL1A1 was not
a major susceptibility gene. However, they reported that
the allelic frequency of these markers in the Chinese popu-
lation differed signiﬁcantly from that observed in two Cauca-
sian populations, thus retaining the possibility of an
association between COL1A1 and CDH within populations
of other ethnic origins. A recent study reported that mRNA
and protein expression of COL1A1 was signiﬁcantly de-
creased in the capsule of children with development dislo-
cation of the hip44. Despite these experimental ﬁndings,
our study indicates that COL1A1 does not play a major
role in the etiology of CDH in our Caucasian population.
In 2007, an English team tested the association between
two genes involved in metabolism and development of bone
and developmental hip dysplasia (DDH): ESR1 encoding
the estrogen receptor (located on chromosome 6) and
VDR encoding the vitamin D receptor (located on chromo-
some 12)41. The authors, who carried out a case-control
study (45 patients and 101 controls), selected two polymor-
phisms within each gene and observed no signiﬁcant
association.
Another case-control association study was conduced by
an Italian team in 2002, but not directly on CDH. This study,
based on 143 patients and 50 controls, analyzed the role of
two adjacent genes on the chromosome 12 (COL2A1 and
VDR) in osteoarthritis secondary to hip dysplasia45. One ge-
netic marker was genotyped in each gene, and a signiﬁcant
association was found with the marker selected in COL2A1
(P¼ 0.03). However, the role of these two genes in DDH
was recently excluded by a linkage study done from a panel
of 11 families (study based on the analysis of three micro-
satellite markers covering the region containing these two
genes)42. An other linkage study, based on a genomewide
screening, was done in a Japanese family with osteoarthri-
tis of the hip joint associated with acetabular dysplasia, and
revealed a region of interest on the chromosome 13
(13q22)46.
The ﬁrst report of a positive association between one
gene and CDH was done very recently by a Chinese
1104 K. Rouault et al.: Role of COL1A1 and HOXB9 in CDHteam43. This case-control study, based on 338 patients and
622 controls, found a signiﬁcant association between a func-
tional SNP (rs143383) located in the 50UTR of the GDF5
(growth differentiate factor 5) gene which plays a crucial
role in joint morphogenesis. This SNP was already found
to be associated with osteoarthritis susceptibility in both
Asian and European populations47e49.
In conclusion, to date, only one gene involved in the eti-
ology of CDH has been reported (GDF5). The other studies
have excluded the role of several genes in CDH (COL1A1
in a Chinese population) or in DDH (COL2A1, ESR1 and
VDR in Caucasian populations). Our study do not support
the involvement of HOXB9 and COL1A1 in a Caucasian
population.
Analysis of the genetic component of CDH needs further
investigations and should focus on other candidate genes.
Identiﬁcation of the genetic factors involved in CDH should
advance understanding of the respective roles of genetic
and environmental factors in that complex disease. It would
furthermore avoid late diagnosis and treatment, and pro-
mote earlier identiﬁcation of patients at risk of developing
hip osteoarthritis.
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